methylprednisolone hemisuccinate has been researched along with alendronate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bahremand, A; Dehpour, AR; Derakhshanian, H; Djalali, M; Djazayery, A; Ghadbeigi, S; Nourijelyani, K; Pishva, H; Saedisomeolia, A | 1 |
2 other study(ies) available for methylprednisolone hemisuccinate and alendronate
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quercetin prevents experimental glucocorticoid-induced osteoporosis: a comparative study with alendronate.
Topics: Alendronate; Animals; Biomarkers; Body Mass Index; Bone Density Conservation Agents; Disease Models, Animal; Female; Femur; Glucocorticoids; Methylprednisolone Hemisuccinate; Osteogenesis; Osteoporosis; Pilot Projects; Quercetin; Random Allocation; Rats; Rats, Sprague-Dawley | 2013 |